Stony Brook University Medical Center – FDA 483, Feb 7, 2023
An FDA inspection of Stony Brook University Medical Center's blood bank revealed significant deficiencies in reporting, record-keeping, and standard operating procedures. The facility failed to submit biological product deviation reports for numerous incidents involving blood product expiration dates, mislabeling, and incorrect patient issuance. Additionally, the inspection found inadequate quality control records for blood warmers and incomplete SOPs for blood collection, storage, and distribution, including donor screening and product visual inspection.
ID · 36c6c4ee-219d-422d-9634-707e185cfe44
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.